ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 097,68
-0,54%
Dow Jones
39 872,99
0,00%
DAX
18 684,54
-0,22%
Brent Oil
82,01
-0,53%
Bitcoin
69 857,93
-0,39%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Ambrx Biopharma Inc (AMAM)

  7. Ambrx Biopharma Inc (AMAM) Actualités

AMAM

Ambrx Biopharma (AMAM)

Ambrx Biopharma Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:AMAM
DateHeureSourceTitreSymboleSociété
18/03/202419h45Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:AMAMAmbrx Biopharma Inc
12/03/202421h55Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AMAMAmbrx Biopharma Inc
11/03/202405h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:AMAMAmbrx Biopharma Inc
08/03/202419h39Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:AMAMAmbrx Biopharma Inc
07/03/202419h23Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:AMAMAmbrx Biopharma Inc
23/02/202420h09Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:AMAMAmbrx Biopharma Inc
12/02/202419h43PR Newswire (US)Kuehn Law Encourages AMAM, DOOR, CBAY, and WISH Investors to Contact Law FirmNASDAQ:AMAMAmbrx Biopharma Inc
10/01/202421h07PR Newswire (US)Kuehn Law Encourages AMAM, HARP, AXNX, and CPE Investors to Contact Law FirmNASDAQ:AMAMAmbrx Biopharma Inc
08/01/202420h54Dow Jones NewsTrending: Johnson & Johnson and Merck & Co. Announce AcquisitionsNASDAQ:AMAMAmbrx Biopharma Inc
08/01/202416h04Dow Jones NewsAmbrx Biopharma Shares Double on $2 Billion Acquisition by Johnson & JohnsonNASDAQ:AMAMAmbrx Biopharma Inc
08/01/202414h12Dow Jones NewsJohnson & Johnson to Acquire Cancer-Treatment Developer Amrbx for $2 BillionNASDAQ:AMAMAmbrx Biopharma Inc
15/09/202322h27Edgar (US Regulatory)Form DEFM14A - Definitive proxy statement relating to merger or acquisitionNASDAQ:AMAMAmbrx Biopharma Inc
19/07/202315h49Dow Jones NewsAmbrx Biopharma Gets Fast Track Designation for ARX517 Cancer TreatmentNASDAQ:AMAMAmbrx Biopharma Inc
28/06/202322h46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMAMAmbrx Biopharma Inc
28/06/202322h45Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:AMAMAmbrx Biopharma Inc
28/06/202322h07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AMAMAmbrx Biopharma Inc
25/05/202322h08Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:AMAMAmbrx Biopharma Inc
18/05/202322h28Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:AMAMAmbrx Biopharma Inc
16/05/202322h07Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:AMAMAmbrx Biopharma Inc
11/05/202322h08Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AMAMAmbrx Biopharma Inc
05/05/202322h06Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:AMAMAmbrx Biopharma Inc
28/04/202322h22Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:AMAMAmbrx Biopharma Inc
28/04/202322h09Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:AMAMAmbrx Biopharma Inc
27/04/202322h11Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AMAMAmbrx Biopharma Inc
18/04/202322h16Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:AMAMAmbrx Biopharma Inc
03/04/202312h18Edgar (US Regulatory)Seperately Filed Delaying Amendment Under Securities Act Rule 473 to Delay Effectiveness of a 1933 Act Registration Statement (del Am)NASDAQ:AMAMAmbrx Biopharma Inc
30/03/202323h23Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:AMAMAmbrx Biopharma Inc
30/03/202322h10Edgar (US Regulatory)Annual Report (10-k)NASDAQ:AMAMAmbrx Biopharma Inc
 Showing the most relevant articles for your search:NASDAQ:AMAM

Dernières Valeurs Consultées

BIT
1ILMN
Illumina Inc Dl 01
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés